Announcement of Reaccreditation of Laughlin Memorial Hospital’s Cancer Program
The Commission on Cancer (CoC) of the American College of Surgeons (ACoS) has granted a Three-Year Accreditation with Commendation to the Cancer Program at Laughlin Memorial Hospital, first in November 2009 and most recently in December 2015. The ACoS established the CoC in 1922 with the purpose of improving survival rates and the quality of life of cancer patients by setting quality-of-care standards. Applying for and maintaining accreditation is given only to those facilities that voluntarily make this commitment of excellence to cancer patients by complying with 30 quality-of-care standards. During the CoC survey process, which occurs every three years, a facility undergoes a rigorous evaluation and review of their performance and compliance to these quality-of-care standards.
The American Cancer Society estimated that more than 1.6 million cases of cancer would be diagnosed in 2015. Currently, there are more than 1,500 CoC-accredited cancer programs in the US and Puerto Rico, which represent about 30% of all hospitals. These CoC-accredited facilities diagnose and/or treat approximately 70 percent of all newly diagnosed cancer patients each year.
Dr. John Boys, medical director of the Radiation Oncology Center at Laughlin Memorial Hospital, said that achieving accreditation for the hospital’s overall cancer care program involved a tremendous amount of work not only from his department, but virtually the entire hospital. Having a successful survey by the CoC means that the “commission affirms that our services are of the highest quality and surpasses the standard of care nationwide”. Photo: Dr John Boys
“This is a team approach,” Boys said. “People need to know that cancer care has a full-team approach here", Boys added.
Receiving care at a CoC-accredited cancer program ensures that a patient will have access to:
• Full scope of state-of-the-art services and equipment to diagnose and treat cancer.
• Comprehensive, patient-centered care through a multidisciplinary team approach to coordinate the best treatment options.
• Information about ongoing cancer clinical trials and new treatment options.
• Access to prevention and early detection programs, cancer education, rehabilitation, and support services such as psycho-social and survivorship care.
• Cancer registry that collects data on type and stage of cancers and treatment, and lifelong patient follow-up.
• Ongoing monitoring and continuous improvements in patient care.
• Appropriate referral to tertiary care centers when indicated.
And, most importantly,
• Quality care close to home.
Cancer patient data by each CoC-accredited cancer program is reported to the CoC’s National Cancer Data Base (NCDB), a joint CoC/American Cancer Society program. The NCDB currently contains about 29 million records from hospital cancer registries, patients diagnosed and treated at hospital cancer programs in the US. This accounts for almost two-thirds of newly diagnosed cancer cases in the US each year.
NCDB data is utilized routinely to monitor and improve the quality of patient care delivered in CoC-accredited cancer programs. The CoC standards require programs to implement improvement initiatives that promote the delivery of quality, multidisciplinary cancer care and lead ongoing educational interventions with local providers in the CoC-accredited cancer programs.
The CoC partners with the American Cancer Society in an exclusive partnership that provides the public with information on the resources, services and cancer treatment experience for each CoC-accredited cancer program. You can see this information on the ACS’s web site at www.cancer.org
and through the ACS’s National Cancer Information Center at 1-800-ACS-2345. http://datalinks.facs.org/cpm/CPMApprovedHospitals_Search.htm